Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
13.38
+0.02 (0.15%)
At close: Nov 13, 2026, 4:00 PM EST
13.35
-0.03 (-0.22%)
After-hours: Nov 13, 2026, 7:47 PM EST
Alpha Tau Medical Market Cap
Alpha Tau Medical has a market cap or net worth of $1.24 billion as of November 13, 2026. It is the 8,827th most valuable company in the world and the 2,090th biggest in the United States. Its market cap has increased by 265.92% in one year.
Market Cap
1.24B
Enterprise Value
1.15B
1-Year Change
265.92%
Global Rank
Country Rank
#2,090 United States
Category
ChartMarket Cap Chart
Since March 8, 2021, Alpha Tau Medical's market cap has increased from $347.19M to $1.24B, an increase of 255.83%. That is a compound annual growth rate of 25.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 1.24B | 192.71% |
| Dec 31, 2025 | 422.06M | 94.21% |
| Dec 31, 2024 | 217.32M | 3.92% |
| Dec 29, 2023 | 209.12M | -4.71% |
| Dec 30, 2022 | 219.46M | -34.99% |
| Dec 31, 2021 | 337.56M | -2.77% |
| Mar 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ascentage Pharma Group International | 1.32B |
| GH Research | 1.31B |
| Kardigan | 1.29B |
| UroGen Pharma | 1.28B |
| Nektar Therapeutics | 1.28B |
| Omeros | 1.27B |
| Savara | 1.25B |
| Silence Therapeutics | 1.23B |